Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, S.-J.
Right arrow Articles by Chow, N.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, S.-J.
Right arrow Articles by Chow, N.-H.
Clinical Cancer Research Vol. 6, 230-236, January 2000
© 2000 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

The Potential of Soybean Foods as a Chemoprevention Approach for Human Urinary Tract Cancer1

Shu-Jem Su, Trai-Ming Yeh, Huan-Yao Lei and Nan-Haw Chow2

Departments of Microbiology and Immunology [S-J. S., T-M. Y., H-Y. L.], Medical Technology [T-M. Y.], and Pathology [N-H. C.], College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China

Isoflavones are excreted in human urine and can be modulated by soy-rich diets. Recently, isoflavones were suggested to have protective effects against bladder cancer cells. We sought to determine the efficacy of the antitumorigenic effects of isoflavones at concentrations found in the range of human urine excretion and compare normal urothelium and bladder cancer cells for differential cytotoxicity. A total of seven human bladder cancer cell lines and an immortalized uroepithelial cell line were used to examine the effects of genistein, daidzein, and biochanin-A, either individually or as an equal-proportion mixture regimen, on cell growth, DNA synthesis, alterations of cell cycle distribution, and induction of apoptosis. The role of cyclin B1 and cdc2 kinase in cell cycle arrest was analyzed. In addition, severe combined immunodeficient mice were used to confirm the anticancer effects of isoflavones in vivo. Cooperative action of isoflavones was more effective in growth inhibition and apoptosis induction than any single compound. Genistein tends to cause a dose-dependent induction of G2-M cell cycle arrest and an inhibition of cdc2 kinase activity. However, both daidzein and biochanin-A directly induced apoptosis without altering cell cycle distribution. The IC50 values in non-transformed cells were higher than those in most cancer cell lines, and the IC50 of the mixture regimen was within reach of the levels observed in urine after a soy challenge. Furthermore, both genistein and combined isoflavones exhibited a significant tumor suppressor effect in vivo (P < 0.05). The results justify the potential use of soybean foods as a practical chemoprevention approach for patients with urinary tract cancer.




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
T.-T. Ou, C.-J. Wang, G.-U. Hung, C.-H. Wu, and H.-J. Lee
Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway
Evid. Based Complement. Altern. Med., May 25, 2009; (2009) nep016v2.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. L. Johnson, M. B. Lai, J. C. K. Lai, and A. Bhushan
Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A
Evid. Based Complement. Altern. Med., February 29, 2008; (2008) nen011v1.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-C. Pong, R. Roark, J.-Y. Ou, J. Fan, J. Stanfield, E. Frenkel, A. Sagalowsky, and J.-T. Hsieh
Mechanism of Increased Coxsackie and Adenovirus Receptor Gene Expression and Adenovirus Uptake by Phytoestrogen and Histone Deacetylase Inhibitor in Human Bladder Cancer Cells and the Potential Clinical Application.
Cancer Res., September 1, 2006; 66(17): 8822 - 8828.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. V. Singh, A. A. Franke, G. L. Blackburn, and J.-R. Zhou
Soy Phytochemicals Prevent Orthotopic Growth and Metastasis of Bladder Cancer in Mice by Alterations of Cancer Cell Proliferation and Apoptosis and Tumor Angiogenesis
Cancer Res., February 1, 2006; 66(3): 1851 - 1858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Garcia Palacios, L. J. Robinson, C. W. Borysenko, T. Lehmann, S. E. Kalla, and H. C. Blair
Negative Regulation of RANKL-induced Osteoclastic Differentiation in RAW264.7 Cells by Estrogen and Phytoestrogens
J. Biol. Chem., April 8, 2005; 280(14): 13720 - 13727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. D Lambert, J. Hong, G.-y. Yang, J. Liao, and C. S Yang
Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 284S - 291S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Wang, V. L. DeGroff, and S. K. Clinton
Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase
J. Nutr., July 1, 2003; 133(7): 2367 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C.-L. Sun, J.-M. Yuan, K. Arakawa, S.-H. Low, H.-P. Lee, and M. C. Yu
Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1674 - 1677.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.-L. Cheng, B. Trink, T.-S. Tzai, H.-S. Liu, S.-H. Chan, C.-L. Ho, D. Sidransky, and N.-H. Chow
Overexpression of c-met as a Prognostic Indicator for Transitional Cell Carcinoma of the Urinary Bladder: A Comparison With p53 Nuclear Accumulation
J. Clin. Oncol., March 15, 2002; 20(6): 1544 - 1550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.